Skip Navigation
Visitor Restrictions Update: Because flu & RSV cases are on the rise, starting November 16, children 12 and younger are restricted from visiting hospitals, certain inpatient facilities, and all emergency departments. Learn more.

Giselle Saulnier Sholler, MD

  • Pediatric Hematology and Oncology

Giselle Saulnier Sholler, MD

  • Pediatric Hematology and Oncology
Giselle Saulnier Sholler, MD
No Rating
Atrium Health Provider
Accepts New Patients
age-group-children-filled Treats only Children

Ratings and Reviews


Practicing Specialties

  • Pediatric Hematology and Oncology


  • English


“My goal is to help identify new therapies and bring clinical trials to life to impact children today. I’m committed to finding better tolerated and more targeted therapies through precision medicine so children can be cured with less toxic effects than we see with the current chemotherapy.” 

Dr. Sholler is board certified in pediatric hematology-oncology (cancer and blood disorders) and is known around the world for her groundbreaking research. She specializes in pediatric solid tumors with a focus on neuroblastomas, diffuse intrinsic pontine gliomas (DIPG), embryonal tumors with mutilayered rosettes (ETMR) and medulloblastomas. 

She is the director of the Isabella Santos Foundation Rare and Solid Tumor Program at Levine Children’s and the professor of pediatrics and principal investigator of the Sholler Pediatric Oncology Research Laboratory at Levine Children’s Hospital. She is also the chair of the Beat Childhood Cancer Consortium. 

She has been honored with the WGVU Engage Award for Person of the Year in 2015 and the Barton Kamen Metronomics Global Health Initiative Award in 2016. 

Dr. Sholler received her master’s degree in microbiology and immunology at McGill University and her medical degree at New York Medical College. She completed her residency in pediatrics and a fellowship in pediatric hematology-oncology at Brown University. Additionally, she completed a sabbatical through the National Cancer Institute at the National Institutes of Health in Clinical Trials Management and postgraduate work in clinical pharmacology at Tufts University. 

The research she conducts at the Sholler Pediatric Oncology Research Laboratory focuses on 3 main areas. First is the targeting of neuroblastoma cancer stem cells to prevent relapse focused on a drug called DFMO. The second is in precision medicine through testing of novel agents for a panel of cancers including neuroblastomas, brain tumors and sarcomas to develop new clinical trials. The third is in the genomic understanding of patient tumors and generation of individual patient tumor models. 

She loves to travel, ski and hike with her husband and their 2 daughters. She also enjoys running, sprint distance triathlons and volunteering, especially with the Make-a-Wish Foundation.



Board Certifications

  • American Board of Pediatrics, Pediatric Hematology and Oncology

Medical Education

  • New York Medical College


  • Brown University


  • Brown University